In the course of continued studies of the annulation isomers 6-*exo-trig***28** and 5-*exo-trig***32**, the crystal structures of both compounds have now been solved (Schemes [6](#sch6){ref-type="scheme"} and [7](#sch7){ref-type="scheme"}). These structures establish the correct stereochemistry of these compounds as *ribo* \[2′*R*,3′*R*,4′*S*\], not *lyxo* \[2′*R*,3′*R*,4′*R*\] as previously proposed. This corrected assignment explains the puzzling failure to observe the pyranosyl isomer **40**, as the pyranosyl form was only expected to be favored for the sterically crowded *lyxo* \[2′*R*,3′*R*,4′*R*\] isomer (Scheme [7](#sch7){ref-type="scheme"}). However, the corrected stereochemical assignment leads to a new surprise, which is that equal but opposite diastereoselectivity is observed upon the reaction of the 5-aminoimidazole-4-carboxamide (AICA) and 5-aminoimidazole-4-carbonitrile (AICN) glyceraldehyde imines with 2-aminooxazole **5**, resulting in *lyxo* \[2′*R*,3′*R*,4′*R*\] selectivity (60%) and *ribo* \[2′*R*,3′*R*,4′*S*\] selectivity (66%), respectively (Scheme [6](#sch6){ref-type="scheme"}). This reversal of imine/iminium facial selectivity may result from amide hydrogen bonding, which is possible for the AICA but not the AICN derivatives. We apologize for any confusion the incorrect 4′-stereochemical assignment of **28**/**32** may have caused. Corrected versions of Schemes S1 and CIF files for **28** and **32** are available as [Supporting Information](#notes-1){ref-type="notes"}.

![One-Pot Multicomponent Assembly of *rac*-3′-(Dihydroxyethyl)tetrahydroimidazo-2′′-aminooxazolopyrimidines from Glyceraldehyde with Crystal Structures of **24** and **30**](ja-2011-002023_0002){#sch6}

Equilibration of Purified **32** {#sec1}
================================

**32** (20 mg) was dissolved in D~2~O, and over the course of 2 d it was found to equilibrate to a 4:1 mixture of **32**:**28**. The pD of the sample was measured (pD 6.0) and adjusted with DCl (0.01 mM) to pD 2.0, and over 1 d the sample was observed to re-equilibrate to give a mixture of 10:1 **32**:**28**. Further samples of **32** (20 mg) were dissolved in D~2~O at pD 1.0, 4.0, 6.0, 7.0, 8.0, 9.0, and 12.0, and were observed to equilibrate to give mixtures of 50:1, 1:4, 1:4, 1.25:1, 1:1, 3:1, and 5:1 **32**/**28**, respectively, after a period of 3 d. The sample at pD 2.0 was observed to give a ratio of 20:1 after 3 d (Scheme [7](#sch7){ref-type="scheme"}).

![pH-Controlled Isomerization of **32** to **28** in Water after 3 d at Room Temperature\
**28** was crystallized at pH 6.5 from phosphate buffer (10 mM), and the hydrochloride salt of **32** was crystallized from water by evaporation at pH 2.0. CIF files for **28** (CCDC 806657) and **32** (CCDC 806658) have been deposited with the Cambridge Structural Database and are available as [Supporting Information](#notes-1){ref-type="notes"}.](ja-2011-002023_0001){#sch7}

At low pD (pD \< 4), protonation may suppress the nucleophilicity and basicity of the imidazole moiety and increase its leaving group potential, thus kinetically prohibiting and thermodynamically destabilizing **28**, resulting in complete furanosyl selectivity. Evidence for this protonation is provided by the substantial downfield shift of **32**H-(C2) at pD \< 4, but not of **28**H-(C2). Some compound degradation (likely hydrolysis) is observed at high pD (pD \> 9), and significant imidazole deuteration is observed at pD 12.
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Corrected Scheme S1; CIF files for **28** and **32**. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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